New units presentation: Clinical Proteomics Lund

Clinical Proteomics Lund is a new unit within the SciLifeLab Proteomics platform. The unit focuses on large-scale protein analysis in clinically relevant samples, supporting research that connects molecular data to disease mechanisms and patient outcomes.

Proteomics complements genomic and transcriptomic approaches by capturing the functional state of biological systems. By working directly with proteins in samples such as plasma, serum, and tissue, the unit supports studies that are closer to clinical reality and patient variability.

What Clinical Proteomics Lund offers

The unit provides end-to-end support for proteomics studies, from experimental design and sample preparation to data acquisition and interpretation. This ensures that analyses are aligned with the clinical or biological questions from the outset.

Typical applications include identifying disease mechanisms, discovering biomarkers, and understanding differences in treatment response. The unit works with both clinical and pre-clinical researchers, supporting projects across the spectrum from discovery to translational research.

A key focus is on generating robust and reproducible data from complex biological samples. The unit also aims to strengthen links between research and healthcare by working more closely with clinicians and regional hospitals.

Looking ahead, Clinical Proteomics Lund will continue to develop workflows that support scalable and clinically relevant proteomics, with the aim of contributing to improved diagnostics and patient stratification.

Visit the Clinical Proteomics Lund website (go to further information and click on Clinical Proteomics Lund)